Jinzi J. Wu
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Denifanstat for moderate-to-severe acne: A Phase 2, randomized, double-blind, placebo-controlled trial.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: December 26, 2024
Safety, tolerability and pharmacokinetics of ASC10, a novel oral double prodrug of a broad-spectrum antiviral agent, β-d-N4-hydroxycytidine: results from a randomized, double-blind, placebo-controlled phase 1 study in Chinese healthy subjects.
Journal: Expert opinion on investigational drugs
Published: July 11, 2024
A randomized phase 2b study of subcutaneous PD-L1 antibody ASC22 in virally suppressed patients with chronic hepatitis B who are HBeAg-negative.
Journal: Hepatology (Baltimore, Md.)
Published: March 14, 2024
First clinical study using HCV protease inhibitor danoprevir to treat COVID-19 patients.
Journal: Medicine
Published: November 25, 2020
Long-term positive severe acute respiratory syndrome coronavirus 2 ribonucleic acid and therapeutic effect of antivirals in patients with coronavirus disease: Case reports.
Journal: Revista da Sociedade Brasileira de Medicina Tropical
Published: June 18, 2020
Efficacy and Safety of All-oral, 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naïve Noncirrhotic HCV Genotype 1 Patients: Results from a Phase 2/3 Clinical Trial in China.
Journal: Journal of clinical and translational hepatology
Published: July 30, 2019
Efficacy and Safety of 12-week Interferon-based Danoprevir Regimen in Patients with Genotype 1 Chronic Hepatitis C.
Journal: Journal of clinical and translational hepatology
Published: May 13, 2019
Twelve-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin for non-cirrhotic HCV genotype 1 patients: A phase 2 study.
Journal: Journal of gastroenterology and hepatology
Published: November 05, 2017
Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis.
Journal: Journal of gastroenterology and hepatology
Published: December 01, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026